Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysisHisham Mehanna, M. Mena, Francisca Morey et al.|The Lancet Oncology|2023Cited by 291
Human papillomavirus infection in head and neck cancer: The role of the secretory leukocyte protease inhibitorMarkus Hoffmann, W. Martin Kast, Elgar Susanne Quabius et al.|Oncology Reports|2013Cited by 45
911O Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC StudyHisham Mehanna, Laia Alemany, M. Taberna Sanz et al.|Annals of Oncology|2020Cited by 3